GOVERNMENT CONTRACT / DELIVERY ORDER
THE PURPOSE OF THIS TASK ORDER IS TO PROCURE INFLUENZA A/ASTRAKHAN/3212/2020 (H5N8) VIRUS VACCINE CANDIDATE AND CLINICAL TRIAL FOR THE DEPARTMENT OF HEALTH AND HUMAN SERVICES UNDE
Awarded to GLAXOSMITHKLINE, LLC
- Company legal name
- GLAXOSMITHKLINE, LLC
- UEI / CAGE
- FRHTPHMZMX47 / Not reported
- Parent award
- Not reported
- Awarding agency
- Department of Health and Human Services
- Subagency
- Office of Assistant Secretary for Preparedness and Response
- Industry
- Biotechnology & Pharmaceuticals
- NAICS
- 541714
- PSC
- AN12
- Performance period
- Not reported — Not reported
- Recipient address
- 5 MOORE DR RESEARCH TRIANGLE PK, DURHAM, DURHAM, NC, 27709
- Place of performance
- DURHAM, DURHAM, NC, 27709
- Source last modified
- Nov 3, 2026
Description
THE PURPOSE OF THIS TASK ORDER IS TO PROCURE INFLUENZA A/ASTRAKHAN/3212/2020 (H5N8) VIRUS VACCINE CANDIDATE AND CLINICAL TRIAL FOR THE DEPARTMENT OF HEALTH AND HUMAN SERVICES UNDER IDIQ CONTRACT # 75A50122D00002 BASE PERIOD.
Derived from official transactions
Contract lifecycle
- Contract modified
THE PURPOSE OF THIS MODIFICATION IS AS FOLLOWS: TO UPDATE ARTICLE H.3. HHSAR 352.237-75 KEY PERSONNEL (DECEMBER 2015) FOR STUDY DELIVERY LEAD FOR TO 75A50122F61004, CLIN 0013. SER
- Contract modified
THE PURPOSE OF THIS MODIFICATION IS AS FOLLOWS: 1. TO TRANSFER 65K H5N8 VIALS FROM TASK ORDER 75A50122F61004 ( CLIN 0007C) TO TASK ORDER 75A50123F61006.
- Contract modified
THE PURPOSE OF THIS MODIFICATION IS AS FOLLOWS: INCREASE FUNDING FOR TASK ORDER F61004 FROM $19,336,207 BY $3,541,490 TO $22,877,697. (SEE CONTINUATION PAGE) 1. UPDATE THE EX
- Value increased
THE PURPOSE OF THIS MODIFICATION IS AS FOLLOWS: INCREASE FUNDING FOR TASK ORDER F61004 FROM $19,336,207 BY $3,541,490 TO $22,877,697. (SEE CONTINUATION PAGE) 1. UPDATE THE EX
- Contract modified
THE PURPOSE OF THIS TASK ORDER IS TO PROCURE INFLUENZA A/ASTRAKHAN/3212/2020 (H5N8) VIRUS VACCINE CANDIDATE AND CLINICAL TRIAL FOR THE DEPARTMENT OF HEALTH AND HUMAN SERVICES UNDE
- Award announced
THE PURPOSE OF THIS TASK ORDER IS TO PROCURE INFLUENZA A/ASTRAKHAN/3212/2020 (H5N8) VIRUS VACCINE CANDIDATE AND CLINICAL TRIAL FOR THE DEPARTMENT OF HEALTH AND HUMAN SERVICES UNDE
- Value increased
THE PURPOSE OF THIS TASK ORDER IS TO PROCURE INFLUENZA A/ASTRAKHAN/3212/2020 (H5N8) VIRUS VACCINE CANDIDATE AND CLINICAL TRIAL FOR THE DEPARTMENT OF HEALTH AND HUMAN SERVICES UNDE
Point-in-time model
Contract change outlook
Uncollapsed source history
Transactions and modifications
| Action date | Modification | Action type | Exact obligation | Current total | Potential total | Description | Source |
|---|---|---|---|---|---|---|---|
| Sep 21, 2023 | P00004 | M | Not reported | Not reported | Not reported | THE PURPOSE OF THIS MODIFICATION IS AS FOLLOWS: TO UPDATE ARTICLE H.3. HHSAR 352.237-75 KEY PERSONNEL (DECEMBER 2015) FOR STUDY DELIVERY LEAD FOR TO 75A50122F61004, CLIN 0013. SERGE BEUDJEKIAN WILL REPLACE GEETHA BHAT AS STUDY DELIVERY LEAD. | USAspending ↗ |
| Aug 31, 2023 | P00003 | M | Not reported | Not reported | Not reported | THE PURPOSE OF THIS MODIFICATION IS AS FOLLOWS: 1. TO TRANSFER 65K H5N8 VIALS FROM TASK ORDER 75A50122F61004 ( CLIN 0007C) TO TASK ORDER 75A50123F61006. | USAspending ↗ |
| May 16, 2023 | P00002 | M | $3,541,490.00 | Not reported | Not reported | THE PURPOSE OF THIS MODIFICATION IS AS FOLLOWS: INCREASE FUNDING FOR TASK ORDER F61004 FROM $19,336,207 BY $3,541,490 TO $22,877,697. (SEE CONTINUATION PAGE) 1. UPDATE THE EXISTING SOW FOR CLIN 0013 INCLUDED AS ATTACHMENT 1A. 2. REV | USAspending ↗ |
| Oct 13, 2022 | P00001 | B | Not reported | Not reported | Not reported | THE PURPOSE OF THIS TASK ORDER IS TO PROCURE INFLUENZA A/ASTRAKHAN/3212/2020 (H5N8) VIRUS VACCINE CANDIDATE AND CLINICAL TRIAL FOR THE DEPARTMENT OF HEALTH AND HUMAN SERVICES UNDER IDIQ CONTRACT # 75A50122D00002 BASE PERIOD. | USAspending ↗ |
| Sep 14, 2022 | 0 | Not reported | $19,336,207.00 | Not reported | Not reported | THE PURPOSE OF THIS TASK ORDER IS TO PROCURE INFLUENZA A/ASTRAKHAN/3212/2020 (H5N8) VIRUS VACCINE CANDIDATE AND CLINICAL TRIAL FOR THE DEPARTMENT OF HEALTH AND HUMAN SERVICES UNDER IDIQ CONTRACT # 75A50122D00002 BASE PERIOD. | USAspending ↗ |